Botanix Pharmaceuticals Limited (BXPHF) Financials

BXPHF Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 65.8 million 29.8 million
June 30, 2025 84.9 million 31.4 million
Dec. 31, 2024 61.8 million 4.3 million
June 30, 2024 75.1 million 2.5 million

BXPHF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -21.8 million ?
June 30, 2025 -31.7 million 6.5 million
Dec. 31, 2024 -19.0 million 6.6 million
June 30, 2024 -3.0 million 1.9 million

BXPHF Net Income

No data available :(

BXPHF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 21.1 million 11.3 million 414517
June 30, 2025 42.7 million 15.0 million 800814
Dec. 31, 2024 30.1 million 363136 538328
June 30, 2024 52.9 million - -

BXPHF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 1.3 billion
June 30, 2025 1.2 billion
Dec. 31, 2024 1.1 billion
June 30, 2024 1.0 billion

BXPHF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 1515 - 3.2 million -
June 30, 2025 128829 3862 34.6 million 19.5 million
Dec. 31, 2024 56250 85797 18.7 million 5.5 million
June 30, 2024 51072 557075 3.6 million -287140

BXPHF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 11.0 million 30.2 million
June 30, 2025 3.6 million 1.7 million
Dec. 31, 2024 234629 751016
June 30, 2024 1.1 million 1.8 million

BXPHF

Price: $0.02

52 week price:
0.01
0.14

Payout Ratio Range:
-711.54%
1040.91%

Earnings Per Share: -0.03 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 29.9 million

Links: